← FDA Drug Approvals (Drugs@FDA)
ESOMEPRAZOLE MAGNESIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON INC · Approved 2023-03-28
Drug application
- FDA Application #
ANDA214920- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ESOMEPRAZOLE MAGNESIUM
- Generic name
- ESOMEPRAZOLE MAGNESIUM
- Active ingredients
- ESOMEPRAZOLE MAGNESIUM
- Dosage form
- CAPSULE, DELAYED REL PELLETS
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- PRINSTON INC
- Manufacturer
- Solco Healthcare US LLC
- First approval
- 2023-03-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown